Comparing Aurovela Fe 1/20 vs Yaz
| Aurovela Fe 1/20 | Yaz |
|
|---|
| Aurovela Fe 1/20 (ethinyl estradiol / norethindrone) | Yaz (drospirenone / ethinyl estradiol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Birth Control. Aurovela Fe 1/20 may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Premenstrual Dysphoric Disorder, Acne, Birth Control. Yaz may also be used for purposes not listed in this medication guide. |
Related suggestions Birth Control
|
|||||||||||||||
| More about Aurovela Fe 1/20 (ethinyl estradiol / norethindrone) | More about Yaz (drospirenone / ethinyl estradiol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Aurovela Fe 1/20 has an average rating of 3.4 out of 10 from a total of 109 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 69% reported a negative effect. |
Yaz has an average rating of 5.9 out of 10 from a total of 992 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Aurovela Fe 1/20 side effects in more detail. |
See also: Yaz side effects in more detail. |
||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Aurovela Fe 1/20 prices |
View all Yaz prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / norethindrone brands include: Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Brevicon, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyclafem 0.5/35, Cyclafem 1/35, Cyclafem 7/7/7, Cyonanz, Dasetta, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Femcon Fe, femhrt, Femlyv, Finzala, Fyavolv, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Jinteli, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Lo Loestrin Fe, Loestrin 21 1/20, Lomedia 24 Fe, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Oshih, Philith, Pirmella 1/35, Pirmella 7/7/7, Rhuzdah, Tarina 24 Fe, Tarina Fe 1/20, Taysofy, Taytulla, Tilia Fe, Tri-Legest, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Zenchent, Zenchent Fe View more | Other drospirenone / ethinyl estradiol brands include: Gianvi, Jasmiel, Lo-Zumandimine, Loryna, Melamisa, Nikki, Ocella, Syeda, Yaela, Yasmin, Zarah, Zumandimine View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
14 hours |
32.5 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 467 drugs are known to interact with Aurovela Fe 1/20:
|
A total of 558 drugs are known to interact with Yaz:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
March 16, 2006 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.